APA (7th ed.) Citation

Thompson, J. A., Motzer, R. J., Molina, A. M., Choueiri, T. K., Heath, E. I., Redman, B. G., . . . Kollmannsberger, C. K. (2018). Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell Carcinomas. Clinical Cancer Research, 24(18), 4399-4406. https://doi.org/10.1158/1078-0432.ccr-18-0481

Chicago Style (17th ed.) Citation

Thompson, John A., et al. "Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell Carcinomas." Clinical Cancer Research 24, no. 18 (2018): 4399-4406. https://doi.org/10.1158/1078-0432.ccr-18-0481.

MLA (9th ed.) Citation

Thompson, John A., et al. "Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell Carcinomas." Clinical Cancer Research, vol. 24, no. 18, 2018, pp. 4399-4406, https://doi.org/10.1158/1078-0432.ccr-18-0481.